ANAHEIM, CA, Feb. 28, 2024 (GLOBE NEWSWIRE) — via NewMediaWire – BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative treatment programs for substance use and related disorders, announced that its subsidiary BioCorRx Pharmaceuticals Inc. has been awarded a 3-year grant for approximately $11 million…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
